AzTrials
AzTrials

Lateral EpicondylitisNCT03978897

Trial of Blood Flow Restriction Plus Physical Therapy vs. Physical Therapy Alone for Lateral Epicondylitis

A study testing Blood flow restriction tourniquet and Evidence based physical/occupational therapy in people with Lateral Epicondylitis, run by Cleveland Clinic Akron General at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Open label randomized controlled trial comparing evidenced based physical/occupational therapy vs. physical/occupational therapy including blood flow restriction tourniquet in the treatment of lateral epicondylitis (tennis elbow). Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Lateral Epicondylitis
What is being tested?
Blood flow restriction tourniquet and Evidence based physical/occupational therapy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
41 participants
Where
1 siteUnited States
Study dates
1 Jul 2019to 31 Dec 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • The diagnoses included are lateral elbow pain, lateral epicondylitis, or lateral epicondylalgia, more general diagnoses elbow tendinitis or elbow pain will be included if their clinical picture at physical therapy meets criteria for lateral epicondylitis.
  • If the inclusion diagnosis is other than lateral epicondylitis or tennis elbow (such as elbow pain), we will confirm the diagnosis at the first therapy visit with tenderness at the lateral epicondyle and/or pain with resisted wrist/long finger extension at the lateral epicondyle.
  • Pain for 4 weeks or more.
  • All participants must be between the age of 18 and 70 years old and have had pain for 4 weeks or more.

Who cannot join

  • Ligamentous elbow sprain, osteoarthritis of elbow and cervical radiculopathy in the affected limb will be excluded from the study.
  • Any history of ligamentous, bony or other soft tissue reconstruction surgery at the affected elbow,
  • Vascular disorders to include: history of DVT, history of endothelial dysfunction, peripheral vascular disease
  • Injection therapy (corticosteroid, platelet rich plasma, or other injection therapy) in the prior 3 months to the affected site
  • Current fracture in affected arm
  • History of crush injury to affected arm
Show all 16Show fewer
  • Any surgery on affected arm in last 1 year
  • Surgical procedure on their contralateral extremity (Changed 9/2019 to surgery within last year on contralateral upper extremity).
  • History of lymphectomy (such as axillary exploration with breast surgery, lymph node biopsy in the affected axilla/arm)
  • Pregnancy
  • Active infection
  • Current cancer diagnosis/treatment
  • Sickle cell anemia or trait
  • Kidney dialysis
  • History of syncope/passing out with pressure to body (such as massage, or blood pressure cuff).
  • inability to consent

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Cleveland Clinic Akron General

    Akron, Ohio, 44307

Other trials in United States

About this study

Official title: A Randomized Controlled Trial of Blood Flow Restriction Plus Conventional Physical Therapy vs. Conventional Physical Therapy Alone in the Treatment of Lateral Epicondylitis

Open label randomized controlled trial comparing evidenced based physical/occupational therapy vs. physical/occupational therapy including blood flow restriction tourniquet in the treatment of lateral epicondylitis (tennis elbow).

Read the detailed description

Patients will be randomized to one of two groups, and treatment will be open label and unblinded. A target of 44 patients for enrollment has been set for 80% power, actual enrollment resulted in 41 patients undergoing randomization. Treatment will last for 6 visits with physical therapy with recommended visit intervals of 1 week :

Intervention Group: Evidence based physical/occupational therapy, with the addition of therapeutic exercises using a blood flow restriction tourniquet.

Control Group: Patients will receive standard evidence based physical therapy

The primary outcome (Patient-Rated Tennis Elbow Evaluation [PRTEE]) will be collected at enrollment, 3, 6, and 12 months.

Secondary outcomes will be collected at the beginning and end of physical therapy interventions (change in: numeric pain rating scale, maximum pain free grip strength, pain free grip strength). We will collect treatments received after the end of physical therapy and before final follow up.

Being tested
Blood flow restriction tourniquet, Evidence based physical/occupational therapy
Keywords
lateral epicondylitis, tennis elbow, blood flow restriction, physical therapy
Medical subject headings
Tennis Elbow

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Blood flow restriction tourniquetDevice

    Also called Delfi personalized tourniquet system

    A blood flow restriction tourniquet, which impedes arterial flow to extremity at 50% of usual flow.

  • Evidence based physical/occupational therapyOther

    Up to date physical/occupational therapy for lateral epicondylitis

Study groups in NCT03978897
Study groupRoleWhat they receive
Blood flow restriction with physical/occupational therapyExperimentalphysical/occupational therapy including use of blood flow restriction tourniquet over 6 visits (within a twelve week period).
Receives: Device: Blood flow restriction tourniquet
Evidence based physical/occupational therapyActive comparatorevidence based physical/occupational therapy program over 6 visits (within a twelve week period) without use of blood flow restriction tourniquet
Receives: Other: Evidence based physical/occupational therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Patient Rated Tennis Elbow Evaluation (PRTEE)

    Change in score on 'Patient rated tennis elbow evaluation' total score from baseline to 12 month final follow up. Lower numbers suggest less pain, higher scores suggest more pain. Total score 0-100.

    Includes pain subscale (0-50)

    Specific activities subscale (0-60)

    Usual activities subscale (0-40)

    Function Subscale= (specific activities score + usual activities score)/2 (0-50)

    Total Score= Pain subscale + Function Subscale (0-100)

    Measured: 12 months

Secondary outcomes (4)
  1. Numeric Pain Rating Scale

    change in score from baseline to final 12 month follow up on 0-10 pain rating scale with 0 being no pain, and 10 being worst pain.

    Measured: 12 months

  2. Pain Free Grip Strength

    Change in pain free grip strength (kg) on dynamometer from baseline to final PT visit (approximately 12 weeks)

    Measured: at final therapy visit up to 12 weeks after enrollment

  3. Maximum Grip Strength

    Change in maximum grip strength (kg) on dynamometer from baseline visit to final PT visit (approximately 12 weeks)

    Measured: at final therapy visit up to 12 weeks after enrollment

  4. Other Treatments Received

    We will collect data on whether the patient sought or received treatments beyond physical/occupational therapy over the 12 months of enrollment in the study

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jun 2019
  2. Study start1 Jul 2019
  3. Primary completion31 Dec 2024
  4. Study completion31 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
41 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03978897
Sponsor's protocol ID
19001
Status last verified
Apr 2026
First submitted
24 May 2019
Last updated
5 May 2026
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Blood flow restriction tourniquet and Evidence based physical/occupational therapy in people with Lateral Epicondylitis, run by Cleveland Clinic Akron General at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 5 May 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Patient Rated Tennis Elbow Evaluation (PRTEE) (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in